Checkmate Pharmaceuticals, Inc.
CMPIDelisted May 31, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Checkmate Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q1 2021
- Shares held
- 16.3M
- −361.7K (−2.2%) vs. Q1 2021
- Total value
- $97.3M
- −$105.3M (−52.0%) vs. Q1 2021
- New holders
- 9
- 4 more added
- Sold out
- 12
- 11 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 26 | $54.8M |
| Q4 2021 | 25 | $46.3M |
| Q3 2021 | 32 | $64.5M |
| Q2 2021 | 34 | $97.3M |
| Q1 2021 | 37 | $202.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Checkmate Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 77 | $0 | 0.00% | −4,581−98.3% | Reduced |
| Wells Fargo & Company | 32 | $0 | 0.00% | −2,823−98.9% | Reduced |
| Citigroup Inc | 1 | $0 | 0.00% | −621−99.8% | Reduced |
| Johnson Midwest Financial, LLC | 200 | $1.00K | 0.00% | +200 | New |
| Morgan Stanley | 392 | $2.00K | 0.00% | +69+21.4% | Added |
| US Bancorp | 2,000 | $12.0K | 0.00% | +2,000 | New |
| Royal Bank of Canada | 2,387 | $14.0K | 0.00% | +1,364+133.3% | Added |
| UBS Group AG | 3,296 | $20.0K | 0.00% | +340+11.5% | Added |
| The PNC Financial Services Group, Inc. | 5,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,157 | $31.0K | 0.00% | −19,960−79.5% | Reduced |
| Bank of America Corp | 6,331 | $37.0K | 0.00% | −4,033−38.9% | Reduced |
| Advisory Services Network, LLC | 7,800 | $46.0K | 0.00% | +7,800 | New |
| Federated Hermes, Inc. | 16,169 | $96.0K | 0.00% | −10,781−40.0% | Reduced |
| Bridgeway Capital Management, LLC | 21,500 | $128.0K | 0.00% | −50,015−69.9% | Reduced |
| BlackRock Inc. | 22,850 | $137.0K | 0.00% | −345,376−93.8% | Reduced |
| Renaissance Technologies LLC | 23,500 | $140.0K | 0.00% | +23,500 | New |
| HRT Financial LP | 24,121 | $143.0K | 0.00% | +24,121 | New |
| Cambridge Trust Co | 24,609 | $147.0K | 0.01% | 00.0% | Unchanged |
| Alberta Investment Management Corp | 25,000 | $149.0K | 0.00% | +25,000 | New |
| Ergoteles LLC | 26,427 | $158.0K | 0.00% | +26,427 | New |
| Geode Capital Management, LLC | 40,272 | $240.0K | 0.00% | −63,153−61.1% | Reduced |
| Millennium Management LLC | 40,422 | $241.0K | 0.00% | +40,422 | New |
| RBF Capital, LLC | 68,834 | $410.0K | 0.02% | +68,834 | New |
| Ensign Peak Advisors, Inc | 119,915 | $714.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 134,760 | $803.0K | 0.00% | −3,199−2.3% | Reduced |
| Vanguard Group Inc | 336,587 | $2.00M | 0.00% | −39,424−10.5% | Reduced |
| Sectoral Asset Management Inc | 541,766 | $3.23M | 0.26% | 00.0% | Unchanged |
| FMR LLC | 966,226 | $5.76M | 0.00% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 1,335,050 | $7.96M | 0.90% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $8.95M | 1.60% | 00.0% | Unchanged |
| Clough Capital Partners L P | 1,567,326 | $9.34M | 0.52% | +215,013+15.9% | Added |
| Novo Holdings A/S | 2,170,100 | $12.9M | 0.57% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,606,707 | $21.5M | 1.31% | 00.0% | Unchanged |
| venBio Partners LLC | 3,673,374 | $21.9M | 2.58% | 00.0% | Unchanged |
| State Street Corp | 0 | $0 | 0.00% | −83,259−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −81,359−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −19,146−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −17,188−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −13,503−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −5,217−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,976−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −876−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −608−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −430−100.0% | Sold out |